These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8704301)

  • 1. Distinctive serial magnetic resonance changes in a young woman with rapidly evolved neurocysticercosis, with positron emission tomography results.
    Nagayama M; Shinohara Y; Nagakura K; Izumi Y; Takagi S
    J Neuroimaging; 1996 Jul; 6(3):198-201. PubMed ID: 8704301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albendazole and praziquantel treatment in neurocysticercosis of the fourth ventricle.
    Proaño JV; Madrazo I; García L; García-Torres E; Correa D
    J Neurosurg; 1997 Jul; 87(1):29-33. PubMed ID: 9202261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Praziquantel therapy in neurocysticercosis.
    Aggarwal SP; Sabharwal BD
    J Assoc Physicians India; 1995 May; 43(5):356-7. PubMed ID: 9081969
    [No Abstract]   [Full Text] [Related]  

  • 4. MR observations on the effects of praziquantel in neurocysticercosis.
    Jena A; Sanchetee PC; Tripathi R; Jain RK; Gupta AK; Sapra ML
    Magn Reson Imaging; 1992; 10(1):77-80. PubMed ID: 1545685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superimposition of PET images using 18F-fluorodeoxyglucose with magnetic resonance images in patients with pancreatic carcinoma.
    Benyounes H; Smith FW; Campbell C; Evans NT; Norton MY; Mikecz P; Heys SD; Bruce D; Eremin O; Sharp PF
    Nucl Med Commun; 1995 Jul; 16(7):575-80. PubMed ID: 7478396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral cysticercosis manifesting as hydrocephalus--case report.
    Oka Y; Fukui K; Shoda D; Abe T; Kumon Y; Sakaki S; Torii M
    Neurol Med Chir (Tokyo); 1996 Sep; 36(9):654-8. PubMed ID: 8913084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case report: neurocysticercosis in pregnancy.
    Paparone PW; Menghetti RA
    N J Med; 1996 Feb; 93(2):91-4. PubMed ID: 8837839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cerebral cysticercosis: imaging, serology, treatment and evolution. Apropos of 2 cases].
    Gari-Toussaint M; Marty P; Lanteri-Minet M; Barres P; Hoffman P; Onzon D; Richelme C; Cervera P; Mary C; Coussement A
    Bull Soc Pathol Exot Filiales; 1988; 81(5):869-76. PubMed ID: 3240570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Freely mobile cysticercus in the anterior chamber.
    Sachdeva RS; Manchanda SK; Abrol S; Wadhwa SC; Ramachandran KA
    Indian J Ophthalmol; 1995 Sep; 43(3):135-6. PubMed ID: 8822489
    [No Abstract]   [Full Text] [Related]  

  • 10. Large cerebral infarction during praziquantel therapy in neurocysticercosis.
    Bang OY; Heo JH; Choi SA; Kim DI
    Stroke; 1997 Jan; 28(1):211-3. PubMed ID: 8996514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A kinetic comparison of [18F]2-fluoro-2-deoxyglucose and [18F]2-fluoro-2-deoxymannose using positron emission tomography.
    Braun AR; Carson RE; Adams HR; Finn RD; Francis BE; Herscovitch P
    Nucl Med Biol; 1994 Aug; 21(6):857-63. PubMed ID: 9234335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cerebral cysticercosis].
    Hagelskjaer LH; Hansen NJ; Christensen T
    Ugeskr Laeger; 1991 Sep; 153(39):2754-5. PubMed ID: 1949294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral cysticercosis successfully treated with praziquantel.
    Braconier JH; Christensson B
    Scand J Infect Dis; 1988; 20(1):105-8. PubMed ID: 3363299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability.
    Baer FM; Voth E; Schneider CA; Theissen P; Schicha H; Sechtem U
    Circulation; 1995 Feb; 91(4):1006-15. PubMed ID: 7850935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinctive MRI findings in a case of neurocysticercosis.
    Silbert PL; Gubbay SS; Khangure M
    Med J Aust; 1993 Aug; 159(3):185-6. PubMed ID: 8336620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: a controlled positron emission tomography study.
    Otte A; Weiner SM; Peter HH; Mueller-Brand J; Goetze M; Moser E; Gutfleisch J; Hoegerle S; Juengling FD; Nitzsche EU
    Eur J Nucl Med; 1997 Jul; 24(7):787-91. PubMed ID: 9211766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncertainties in the diagnosis of brain cysticercosis.
    Corona T; Rivera C
    AJNR Am J Neuroradiol; 1995 Jan; 16(1):213-4. PubMed ID: 7900596
    [No Abstract]   [Full Text] [Related]  

  • 18. Neurocysticercosis and pure motor hemiparesis.
    Barinagarrementeria F; Del Brutto OH
    Stroke; 1988 Sep; 19(9):1156-8. PubMed ID: 3413814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Marinesco-Sjögren syndrome examined by computed tomography, magnetic resonance, and 18F-2-fluoro-2-deoxy-D-glucose and positron emission tomography.
    Bromberg MB; Junck L; Gebarski SS; McLean MJ; Gilman S
    Arch Neurol; 1990 Nov; 47(11):1239-42. PubMed ID: 2241622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case from practice (272)--cerebral cysticercosis (neurocysticercosis)--infection with larvae of Taenia solium, swine tapeworm].
    Michel-Harder C; Gubler C
    Schweiz Rundsch Med Prax; 1993 Jul; 82(29-30):800-1. PubMed ID: 8362130
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.